NewGenIvf Group Limited Class A Ordinary Shares
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sp… Read more
NewGenIvf Group Limited Class A Ordinary Shares (NIVF) - Net Assets
Latest net assets as of September 2025: $28.74 Million USD
Based on the latest financial reports, NewGenIvf Group Limited Class A Ordinary Shares (NIVF) has net assets worth $28.74 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($35.56 Million) and total liabilities ($6.82 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $28.74 Million |
| % of Total Assets | 80.82% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 16.16 |
NewGenIvf Group Limited Class A Ordinary Shares - Net Assets Trend (2021–2024)
This chart illustrates how NewGenIvf Group Limited Class A Ordinary Shares's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NewGenIvf Group Limited Class A Ordinary Shares (2021–2024)
The table below shows the annual net assets of NewGenIvf Group Limited Class A Ordinary Shares from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-1.48 Million | -109.50% |
| 2023-12-31 | $15.60 Million | -77.17% |
| 2022-12-31 | $68.32 Million | +7567.56% |
| 2021-12-31 | $-914.91K | -- |
Equity Component Analysis
This analysis shows how different components contribute to NewGenIvf Group Limited Class A Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 6421700.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $21.27 Million | % |
| Other Comprehensive Income | $18.88K | % |
| Total Equity | $-1.05 Million | 100.00% |
NewGenIvf Group Limited Class A Ordinary Shares Competitors by Market Cap
The table below lists competitors of NewGenIvf Group Limited Class A Ordinary Shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GBL (EAI.SG)
STU:EAI
|
$790.03K |
|
Barbara Bui SA
PA:BUI
|
$790.09K |
|
Oceanic Wind Energy Inc
PINK:NKWFF
|
$790.26K |
|
KRATOS DEF&SEC - Dusseldorf Stock Exchang
DU:WF5A
|
$790.35K |
|
TORONTO-DOMINION BK
MU:TDB
|
$789.49K |
|
LiveHire Ltd
AU:LVH
|
$788.52K |
|
Nano Magic Inc
PINK:NMGX
|
$788.21K |
|
Payment Financial Technologies Ltd
TA:PMNT
|
$786.90K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NewGenIvf Group Limited Class A Ordinary Shares's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 15,596,533 to -1,048,614, a change of -16,645,147 (-106.7%).
- Net loss of 525,000 reduced equity.
- Other comprehensive income increased equity by 26,163.
- Other factors decreased equity by 16,146,310.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-525.00K | -50.07% |
| Other Comprehensive Income | $26.16K | +2.5% |
| Other Changes | $-16.15 Million | -1539.78% |
| Total Change | $- | -106.72% |
Book Value vs Market Value Analysis
This analysis compares NewGenIvf Group Limited Class A Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $-15.29 | $1.98 | x |
| 2022-12-31 | $1346.34 | $1.98 | x |
| 2023-12-31 | $2.87 | $1.98 | x |
| 2024-12-31 | $-9.21 | $1.98 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NewGenIvf Group Limited Class A Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -9.66%
- • Asset Turnover: 1.52x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-0.94%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | -0.01% | 2.91x | 0.00x | $77.06K |
| 2022 | 0.67% | 7.72% | 0.08x | 1.04x | $-6.37 Million |
| 2023 | -4.43% | -13.45% | 0.24x | 1.37x | $-2.25 Million |
| 2024 | 0.00% | -9.66% | 1.52x | 0.00x | $-420.14K |
Industry Comparison
This section compares NewGenIvf Group Limited Class A Ordinary Shares's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NewGenIvf Group Limited Class A Ordinary Shares (NIVF) | $28.74 Million | 0.00% | 0.24x | $789.85K |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |